Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione (GSH) replenishment aims to restore cellular redox balance by increasing intracellular glutathione levels. GSH is a critical antioxidant involved in detoxification, redox signaling, and amino acid storage. Strategies include direct supplementation with precursors like NAC, induction or stabilization of biosynthetic enzymes, and inhibition of pathways leading to excessive depletion. Impaired glutathione levels are implicated in numerous diseases, including neurodegenerative disorders, liver disease, and cancer.
Replenishing glutathione levels via precursor administration, modulation of de novo synthesis, or salvage pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione replenishment.